United States

SNBL USA receives FDA letter declaring all issues resolved

Wednesday, November 14, 2012 10:24 AM

SNBL USA, an Everett, Wash.-based, wholly owned subsidiary of Shin Nippon Biomedical Laboratories, has received a formal close out letter from the FDA indicating that it has successfully resolved all the issues identified in an August 10, 2010, warning letter.

More... »

GNS Healthcare, Dana-Farber, Mount Sinai to build computer model of multiple myeloma

Tuesday, November 13, 2012 01:57 PM

GNS Healthcare, a healthcare data analytics company, has entered into a collaboration with Dana-Farber Cancer Institute and the Mount Sinai School of Medicine to create a data-driven computer model of multiple myeloma, the second most common blood cancer in the U.S.

More... »

DiscoveRx acquires BioSeek

Tuesday, November 13, 2012 12:40 PM

DiscoveRx, a privately held, venture-backed company based in Fremont, Calif., has agreed to acquire BioSeek, a drug discovery services provider based in South San Francisco.

More... »

GlaxoSmithKline honors healthcare nonprofits with $40,000 IMPACT Awards

Friday, November 9, 2012 02:02 PM

GlaxoSmithKline has announced five recipients of its annual GlaxoSmithKline IMPACT Awards. In total, the North Carolina and Philadelphia-area healthcare nonprofit organizations will receive $200,000 in grant funding ($40,000 each) for providing access to healthcare for the underserved in their communities.

More... »

FDA grants Soligenix Fast Track designation for SGX203 for Crohn's disease

Friday, November 9, 2012 12:44 PM

Soligenix, a development stage biopharmaceutical company based in Princeton, N.J., announced that its drug SGX203, for the treatment of mild-to-moderate pediatric Crohn's disease, has received Fast Track designation from the FDA.

More... »

Takeda to acquire Envoy Therapeutics

Wednesday, November 7, 2012 11:24 AM

Takeda America Holdings, a subsidiary of Japanese, research-based company Takeda Pharmaceutical, has agreed to acquire Envoy Therapeutics, a privately-held drug discovery company based in Jupiter, Fla. Takeda's corporate venture arm, Takeda Ventures, participated in Envoy's series A financing in October 2009.

More... »

Ambit completes $25M financing for AML drug

Wednesday, November 7, 2012 10:36 AM

Ambit Biosciences, a privately held biopharmaceutical company based in San Diego, has closed the first $25 million tranche of a new $50 million preferred stock financing to support continued advancement of its lead drug candidate, quizartinib, for the treatment of acute myeloid leukemia (AML).

More... »

BioNano Genomics launches Irys for complex human genome analysis

Wednesday, November 7, 2012 09:47 AM

BioNano Genomics, a San Diego-based genomics company, has launched its Irys System, an intuitively designed genome mapping system that empowers genomics researchers with a new way of analyzing genomic DNA.

More... »

Greenphire chosen for long-term global trial

Wednesday, November 7, 2012 09:17 AM

King of Prussia, Penn.-based Greenphire, a provider of payment technologies for the clinical trials industry, said its ClinCard Technology Platform has been chosen for use in a large, phase III clinical trial to include more than 1,000 patients across six countries. The trial is expected to last more than five years. 

More... »

CRA, Radiant Research form largest, most therapeutically diverse SMO in U.S.

Monday, November 5, 2012 01:15 PM

CRA Holdings has acquired Radiant Research, a comprehensive research company based in Cincinnati. Clinical Research Advantage (CRA), a provider of research services also owned by CRA Holdings, will be combined with Radiant Research, creating an organization with 57 sites with more than 550 research professionals and an aggressive plan for growth.

More... »